Serum amyloid A induces CCL2 production via formyl peptide receptor-like 1-mediated signaling in human monocytes

Journal of Immunology

Volumn 181, Issue 6, 2008, Pages 4332-4339

  Ha, Young Lee ^a   Sang, Doo Kim ^a   Jae, Woong Shim ^a   Sun, Young Lee ^a   Lee, Hwahyung ^b   Cho, Kyung Hyun ^b   Yun, Jeanho ^a   Bae, Yoe Sik ^a  

^a Dong A University   (South Korea)

^b Yeungnam University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; FORMYLPEPTIDE RECEPTOR LIKE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; SERUM AMYLOID A; FORMYLPEPTIDE RECEPTOR; FPR2 PROTEIN, HUMAN; LIPOXIN RECEPTOR; RECOMBINANT PROTEIN;

ANIMAL CELL; ARTICLE; CELL LINE; CELL MIGRATION; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; MEDIATOR; MONOCYTE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; ADULT; ANIMAL; BIOSYNTHESIS; GENETICS; IMMUNOLOGY; METABOLISM; NEUTROPHIL CHEMOTAXIS; PHYSIOLOGY; RAT; TUMOR CELL LINE;

ADULT; ANIMALS; CELL LINE, TUMOR; CHEMOKINE CCL2; CHEMOTAXIS, LEUKOCYTE; HUMANS; MONOCYTES; RATS; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, LIPOXIN; RECOMBINANT PROTEINS; SERUM AMYLOID A PROTEIN; SIGNAL TRANSDUCTION;

EID: 56149092965     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.6.4332     Document Type: Article

References (52)

1. Li, A. C., and C. K. Glass. 2002. The macrophage foam cell as a target for therapeutic intervention. Nat. Med. 8: 1235-1242. (Pubitemid 35373554)
2. Smith, J. D., E. Trogan, M. Ginsberg, C. Grigaux, J. Tian, and M. Miyata. 1995. Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc. Natl. Acad. Sci. USA 92: 8264-8268.
3. Valente, A. J., D. T. Graves, C. E. Vialle-Valentin, R. Delgado, and C. J. Schwartz. 1988. Purification of a monocyte chemotactic factor secreted by nonhuman primate vascular cells in culture. Biochemistry 27: 4162-4168.
4. Gosling, J., S. Slaymaker, L. Gu, S. Tseng, C. H. Zlot, S. G. Young, B. J. Rollins, and I. F. Charo. 1999. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J. Clin. Invest. 103: 773-778. (Pubitemid 29152622)
5. -/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394: 894-897.
6. Inoue, S., K. Egashira, W. Ni, S. Kitamoto, M. Usui, K. Otani, M. Ishibashi, K. Hiasa, K. Nishida, and A. Takeshita. 2002. Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout mice. Circulation 106: 2700-2706. (Pubitemid 35364925)
7. Uhlar, C. M., and A. S. Whitehead. 1999. Serum amyloid A, the major vertebrate acute-phase reactant. Eur. J. Biochem. 265: 501-523.
8. Jensen, L. E., and A. S. Whitehead. 1998. Regulation of serum amyloid A protein expression during the acute-phase response. Biochem. J. 334: 489-503. (Pubitemid 28457193)
9. Urieli-Shoval, S., R. P. Linke, and Y. Matzner. 2000. Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states. Curr. Opin. Hematol. 7: 64-69. (Pubitemid 30007690)
10. Furlaneto, C. J., and A. Campa. 2000. A novel function of serum amyloid A: a potent stimulus for the release of tumor necrosis factor-α, interleukin-1β, and interleukin-8 by human blood neutrophil. Biochem. Biophys. Res. Commun. 268: 405-408.
11. Koga, T., T. Torigoshi, S. Motokawa, T. Miyashita, Y. Maeda, M. Nakamura, A. Komori, Y. Aiba, T. Uemura, H. Yatsuhashi, et al. 2008. Serum amyloid A-induced IL-6 production by rheumatoid synoviocytes. FEBS Lett. 582: 579-585.
12. Jijon, H. B., K. L. Madsen, J. W. Walker, B. Allard, and C. Jobin. 2005. Serum amyloid A activates NF-κB and proinflammatory gene expression in human and murine intestinal epithelial cells. Eur. J. Immunol. 35: 718-726.
13. Malle, E., A. Steinmetz, and J. G. Raynes. 1993. Serum amyloid A (SAA): an acute phase protein and apolipoprotein. Atherosclerosis 102: 131-146. (Pubitemid 23283948)
14. Badolato, R., J. M. Wang, W. J. Murphy, A. R. Lloyd, D. F. Michiel, L. L. Bausserman, D. J. Kelvin, and J. J. Oppenheim. 1994. Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. J. Exp. Med. 180: 203-209. (Pubitemid 24181069)
15. Su, S. B., W. Gong, J. L. Gao, W. Shen, P. M. Murphy, J. J. Oppenheim, and J. M. Wang. 1999. A seven-transmembrane. G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J. Exp. Med. 189: 395-402.
16. Bae, Y. S., H. Bae, Y. Kim, T. G. Lee, P. G. Suh, and S. H. Ryu. 2001. Identification of novel chemoattractant peptides for human leukocytes. Blood 97: 2854-2862.
17. Bae, Y. S., H. Y. Lee, E. J. Jo, J. I. Kim, H. K. Kang, R. D. Ye, J. Y. Kwak, and S. H. Ryu. 2004. Identification of peptides that antagonize formyl peptide receptor-like 1-mediated signaling. J. Immunol. 173: 607-614.
18. Kang, H. K., H. Y. Lee, M. K. Kim, K. S. Park, Y. M. Park, J. Y. Kwak, and Y. S. Bae. 2005. The synthetic peptide Trp-Lys-Tyr-Met-Val-D-Met inhibits human monocyte-derived dendritic cell maturation via formyl peptide receptor and formyl peptide receptor-like 2. J. Immunol. 175: 685-692.
19. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔCT) method. Methods 25: 402-408. (Pubitemid 34164012)
20. Wu, S. H., X. H. Wu, C. Lu, L. Dong, G. P. Zhou, and Z. Q. Chen. 2006. Lipoxin A4 inhibits connective tissue growth factor-induced production of chemokines in rat mesangial cells. Kidney Int. 69: 248-256. (Pubitemid 43323074)
21. Cho, K. H., and A. Jonas. 2000. A key point mutation (V156E) affects the structure and functions of human apolipoprotein A-I. J. Biol. Chem. 275: 26821-26827.
22. Han, J. M., T. S. Jeong, W. S. Lee, I. Choi, and K. H. Cho. 2005. Structural and functional properties of V156K and A158E mutants of apolipoprotein A-I in the lipid-free and lipid-bound states. J. Lipid Res. 46: 589-596. (Pubitemid 43109795)
23. Esteban, V., M. Ruperez, E. Sanchez-Lopez, J. Rodriguez-Vita, O. Lorenzo, H. Demaegdt, P. Vanderheyden, J. Egido, and M. Ruiz-Ortega. 2005. Angiotensin IV activates the nuclear transcription factor-κB and related proinflammatory genes in vascular smooth muscle cells. Circ. Res. 96: 965-973. (Pubitemid 40712796)
24. Boekhoudt, G. H., Z. Guo, G. W. Beresford, and J. M. Boss. 2003. Communication between NF-κB and Sp1 controls histone acetylation within the proximal promoter of the monocyte chemoattractant protein 1 gene. J. Immunol. 170: 4139-4147.
25. Lee, H. Y., M. K. Kim, K. S. Park, E. H. Shin, S. H. Jo, S. D. Kim, E. J. Jo, Y. N. Lee, C. Lee, S. H. Baek, and Y. S. Bae. 2006. Serum amyloid A induces contrary immune responses via formyl peptide receptor-like 1 in human monocytes. Mol. Pharmacol. 70: 241-248.
26. Badolato, R., J. A. Johnston, J. M. Wang, D. McVicar, L. L. Xu, J. J. Oppenheim, and D. J. Kelvin. 1995. Serum amyloid A induces calcium mobilization and chemotaxis of human monocytes by activating a pertussis toxin-sensitive signaling pathway. J. Immunol. 155: 4004-4010.
27. Johnson, G. L., and R. Lapadat. 2002. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298: 1911-1912. (Pubitemid 35425238)
28. Prossnitz, E. R., O. Quehenberger, C. G. Cochrane, and R. D. Ye. 1993. Signal transducing properties of the N-formyl peptide receptor expressed in undifferentiated HL60 cells. J. Immunol. 151: 5704-5715.
29. Klein, C., J. I. Paul, K. Sauve, M. M. Schmidt, L. Arcangeli, J. Ransom, J. Trueheart, J. P. Manfredi, J. R. Broach, and A. J. Murphy. 1998. Identification of surrogate agonists for the human FPRL-1 receptor by autocrine selection in yeast. Nat. Biotechnol. 16: 1334-1337. (Pubitemid 28547443)
30. Le, Y., W. Gong, B. Li, N. M. Dunlop, W. Shen, S. B. Su, R. D. Ye, and J. M. Wang. 1999. Utilization of two seven-transmembrane G protein-coupled receptors, formyl peptide receptor-like 1, and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation. J. Immunol. 163: 6777-6784.
31. Yang, D., Q. Chen, A. P. Schmidt, G. M. Anderson, J. M. Wang, J. Wooters, J. J. Oppenheim, and O. Chertov. 2000. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J. Exp. Med. 192: 1069-1074.
32. Migeotte, I., E. Riboldi, J. D. Franssen, F. Gregoire, C. Loison, V. Wittamer, M. Detheux, P. Robberecht, S. Costagliola, G. Vassart, et al. 2005. Identification and characterization of an endogenous chemotactic ligand specific for FPRL2. J. Exp. Med. 201: 83-93. (Pubitemid 40130086)
33. Abbas, A., P. J. Fadel, Z. Wang, D. Arbique, I. Jialal, and W. Vongpatanasin. 2004. Contrasting effects of oral versus transdermal estrogen on serum amyloid A (SAA) and high-density lipoprotein-SAA in postmenopausal women. Arterioscler. Thromb. Vasc. Biol. 24: e164-e167.
34. Jonas, A., K. E. Kezdy, and J. H. Wald. 1989. Defined apolipoprotein A-I conformations in reconstituted high density lipoprotein discs. J. Biol. Chem. 264: 4818-4824. (Pubitemid 19092889)
35. Cho, K. H., S. H. Park, J. M. Han, H. C. Kim, Y. K. Choi, and I. Choi. 2006. ApoA-I mutants V156K and R173C promote anti-inflammatory function and antioxidant activities. Eur. J. Clin. Invest. 36: 875-882.
36. Cho, K. H., S. H. Park, J. M. Han, H. C. Kim, Y. J. Chung, I. Choi, and J. R. Kim. 2007. A point mutant of apolipoprotein A-I. V156K, exhibited potent antioxidant and anti-atherosclerotic activity in hypercholesterolemic C57BL/6 mice. Exp. Mol. Med. 39: 160-169.
37. Husebekk, A., B. Skogen, and G. Husby. 1987. Characterization of amyloid proteins AA and SAA as apolipoproteins of high density lipoprotein (HDL): displacement of SAA from the HDL-SAA complex by apoAI and apoAII. Scand. J. Immunol. 25: 375-381. (Pubitemid 18165159)
38. Khovidhunkit, W., M. S. Kim, R. A. Memon, J. K. Shigenaga, A. H. Moser, K. R. Feingold, and C. Grunfeld. 2004. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J. Lipid Res. 45: 1169-1196. (Pubitemid 38802622)
39. O'Brien, K. D., and A. Chait. 2006. Serum amyloid A: the "other" inflammatory protein. Curr. Atheroscler. Rep. 8: 62-68.
40. Fyfe, A. I., L. S. Rothenberg, F. C. DeBeer, R. M. Cantor, J. I. Rotter, and A. J. Lusis. 1997. Association between serum amyloid A proteins and coronary artery disease: evidence from two distinct arteriosclerotic processes. Circulation 96: 2914-2919.
41. Lewis, K. E., E. A. Kirk, T. O. McDonald, S. Wang, T. N. Wight, K. D. O'Brien, and A. Chait. 2004. Increase in serum amyloid a evoked by dietary cholesterol is associated with increased atherosclerosis in mice. Circulation 110: 540-545.
42. O'Brien, K. D., T. O. McDonald, V. Kunjathoor, K. Eng, E. A. Knopp, K. Lewis, R. Lopez, E. A. Kirk, A. Chait, T. N. Wight, et al. 2005. Serum amyloid A and lipoprotein retention in murine models of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 25: 785-790.
43. Liao, F., A. J. Lusis, J. A. Berliner, A. M. Fogelman, M. Kindy, M. C. de Beer, and F. C. de Beer. 1994. Serum amyloid A protein family: differential induction by oxidized lipids in mouse strains. Arterioscler. Thromb. 14: 1475-1479. (Pubitemid 24282647)
44. Bausserman, L. L., P. N. Herbert, R. Rodger, and R. J. Nicolosi. 1984. Rapid clearance of serum amyloid A from high-density lipoproteins. Biochim. Biophys. Acta 792: 186-191. (Pubitemid 14185110)
45. Coetzee, G. A., A. F. Strachan, D. R. van der Westhuyzen, H. C. Hoppe, M. S. Jeenah, and F. C. de Beer. 1986. Serum amyloid A-containing human high density lipoprotein 3: density, size, and apolipoprotein composition. J. Biol. Chem. 261: 9644-9651.
46. Malle, E., and F. C. de Beer. 1996. Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice. Eur. J. Clin. Invest. 26: 427-435. (Pubitemid 26226404)
47. Cho, K. H., J. E. Park, Y. O. Kim, I. Choi, J. J. Kim, and J. R. Kim. 2008. The function, composition, and particle size of high-density lipoprotein were severely impaired in an oliguric phase of hemorrhagic fever with renal syndrome. Clin. Biochem. 41: 56-64.
48. Selvaraj, S. K., R. K. Giri, N. Perelman, C. Johnson, P. Malik, and V. K. Kalra. 2003. Mechanism of monocyte activation and expression of proinflammatory cytochemokines by placenta growth factor. Blood 102: 1515-1524.
49. Burleigh, M. E., V. R. Babaev, J. A. Oates, R. C. Harris, S. Gautam, D. Riendeau, L. J. Marnett, J. D. Morrow, S. Fazio, and M. F. Linton. 2002. Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice. Circulation 105: 1816-1823.
50. Burleigh, M. E., V. R. Babaev, P. G. Yancey, A. S. Major, J. L. McCaleb, J. A. Oates, J. D. Morrow, S. Fazio, and M. F. Linton. 2005. Cyclooxygenase-2 promotes early atherosclerotic lesion formation in ApoE-deficient and C57BL/6 mice. J. Mol. Cell. Cardiol. 39: 443-452.
51. Lee, H. Y., M. K. Kim, K. S. Park, Y. H. Bae, J. Yun, J. I. Park, J. Y. Kwak, and Y. S. Bae. 2005. Serum amyloid A stimulates matrix-metalloproteinase-9 upregulation via formyl peptide receptor like-1-mediated signaling in human monocytic cells. Biochem. Biophys. Res. Commun. 330: 989-998.
52. Scott, M. G., D. J. Davidson, M. R. Gold, D. Bowdish, and R. E. Hancock. 2002. The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J. Immunol. 169: 3883-3891.